ArticleFrontiers in pharmacology2022

Long-Term Biocompatibility of a Highly Viscously Thiol-Modified Cross-Linked Hyaluronate as a Novel Vitreous Body Substitute.

Jose Hurst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.